The present invention relates to a combination comprising (a) an adenosine
A.sub.2a receptor agonist as define herein and (b) an adrenergic .beta.2
receptor agonist, for simultaneous, sequential or separate administration
by the inhaled route in the treatment of an obstructive airways or other
inflammatory disease.